Search This Blog

Tuesday, July 7, 2026

Fed Appeals Court Rules Sex Offenders Have Constitutional Right To Live With Their Children

 by Matthew Vadum via The Epoch Times,

A federal appeals court ruled July 6 that convicted sex offenders retain a fundamental constitutional right to live with their own children.

The new ruling by the U.S. Court of Appeals for the 11th Circuit arises out of an Alabama case but could help reshape strict sex offender residency laws in the other two states in the circuit—Florida and Georgia—and serve as persuasive authority elsewhere.

At the heart of the case is the constitutional doctrine of substantive due process, which protects certain fundamental rights that are not explicitly listed in the U.S. Constitution but deeply rooted in U.S. history and tradition, including the right of parents to live with and raise their children.

The court ruled 8–5 in favor of the plaintiff, Bruce Henry, in the case known as Henry v. Sheriff of Tuscaloosa County.

The majority opinion was authored by Circuit Judge Robin Rosenbaum.

In 2013, Henry pleaded guilty to “knowingly possess[ing] ... any book, magazine, periodical, film, videotape, computer disk, or any other material that contains an image of child pornography.”

The opinion recounts that the federal district court sentenced him to 70 months in prison and 60 months of supervised release.

He served five years before being released in March 2018.

He finished a qualified Sex Offender Treatment Program, along with individual and group counseling, and continues to attend weekly meetings of Sex Addicts Anonymous. In addition, he has a steady job, attends church, and volunteers.

He violated the terms of supervised release twice by viewing pornography. He reported the violations to his sexual offender treatment provider but did not inform his probation officer. The officer filed a petition to revoke his supervised release, but the district court declined, choosing instead to extend the duration of the supervised release period through March of this year, according to the opinion.

Since the last incident in December 2019, Henry has followed the terms of his release. In August 2021, he and his wife had a son, but because he was a sex offender, the Alabama Sex Offender Registration and Community Notification Act barred him from living with the child.

The Act prohibits a sex offender from residing with or conducting overnight visits with any minor, but it contains a family exception that allows the offender to live with or stay overnight with their own children, grandchildren, step-children, siblings, or step-siblings.

That protection is removed for any adult convicted of a sex offense involving a child or any offense involving child sexual abuse material, legally referred to as child pornography.

“Alabama law affords no offramp to Henry or anyone else: the Act contains no mechanism for offenders to challenge its prohibitions on residing or staying overnight with their own children,” the opinion said.

After Henry’s son was born, he sued officials in Alabama under federal law to block enforcement of the Act’s prohibition against him living with his son. The district court agreed that the prohibition was unconstitutional and enjoined its enforcement.

A panel of the U.S. Court of Appeals for the 11th Circuit ruled largely for Henry, finding that the Act’s prohibition against a parent living with his own child interfered with Henry’s “fundamental right to live with and raise [his] child,” and vacated the district court’s injunction.

The full 11th Circuit then reheard the case and ruled for Henry.

The Supreme Court has recognized that parents have a fundamental right to live with their children, and this right is “perhaps the oldest of the fundamental liberty interests” that the 14th Amendment protects, the opinion said.

By contrast, Alabama argued that not all parents enjoy this right and that entire categories of parents enjoy “no fundamental rights at all because they committed state-defined ‘misconduct’ years before their children were even born.” The Supreme Court has recognized that even a parent convicted of possessing “child pornography” still retains a fundamental right to live with his son, the opinion said.

“That does not mean that Alabama can’t regulate or even abrogate that right. But to do so, Alabama must show that its legislation is narrowly tailored to further its compelling interest in the safety of children,” the appeals court said. Abrogation is the act of formally annulling a law or legal provision.

The appeals court returned the case to the district court for reconsideration.

Chief Circuit Judge William Pryor filed a dissenting opinion, criticizing the majority for undermining Alabama’s child-protection efforts.

“All agree that parents generally enjoy a fundamental right to ‘make decisions concerning the care, custody, and control of their children,’” Pryor said.

“But this appeal presents a different question: whether the Due Process Clause [in the 14th Amendment] grants child-sex convicts, not parents generally, a fundamental right to reside with their children. Of course not.”

Pryor said that using the majority’s reasoning, a father who raped his young child still enjoys the fundamental right to live with that child unless he has been judicially determined to be dangerous.

Pryor also said the doctrine of substantive due process creates a “treacherous field,” and the Supreme Court has directed courts to “exercise the utmost care whenever ... asked to break new ground,” to avoid usurping the authority that the Constitution entrusts to elected legislatures.

https://www.zerohedge.com/political/federal-appeals-court-rules-sex-offenders-have-constitutional-right-live-their-children

MeiraGTx: up to $400 million funding from Oberland Capital to advance gene therapies

 

MeiraGTx secures up to $400 million funding from Oberland Capital to advance AAV2-hAQP1 and bota-vec gene therapies

  • Funding includes up to $375 million in non-dilutive royalty financing from Oberland Capital.
  • Agreement also provides up to $25 million in equity funding to MeiraGTx.
  • Capital will support development and commercialization of AAV2-hAQP1 and bota-vec gene therapy programs.

FDA grants accelerated approval to Vera's TRUTAKNA for proteinuria reduction

 

FDA grants accelerated approval to Vera's TRUTAKNA for proteinuria reduction in adults with primary IgA nephropathy at risk of progression

  • TRUTAKNA, marketed as atacicept-vymj, is indicated to reduce proteinuria in adult primary IgA nephropathy patients.

'UnitedHealth audit finds most home-health diagnoses supported'

 An external review by FTI Consulting found that nearly 97% of diagnoses made by UnitedHealth’s HouseCalls clinicians in 2025 were supported by patient medical records. The audit examined 200 visits covering 494 diagnoses, with 3.4% deemed unsupported. This follows concerns from the Department of Health and Human Services about diagnoses appearing only in home-visit assessments. Reuters + 1

We look at this with both a sense of pride, but also humility," said Wyatt Decker, an executive vice president at UnitedHealth, adding the company aims to make sure that documentation practices by nurse practitioners more accurately reflect diagnoses patients receive.
Wyatt Decker,UnitedHealth executive VP

Why the audit matters 
HouseCalls diagnoses influence Medicare Advantage payments to UnitedHealthcare, which operates plans for seniors and people with disabilities. Federal scrutiny has centered on whether certain diagnoses are documented elsewhere in patient records. The audit’s findings may help reassure regulators and patients but underscore the need for accurate, consistent documentation in payment-linked assessments, similar to broader healthcare technology trends where data accuracy and integration shape trust and adoption. Reuters + 1

UnitedHealth leadership responds to findings
Executive vice president Wyatt Decker said the company views the results with "pride" and "humility," aiming to improve nurse practitioner documentation accuracy. CEO Stephen Hemsley emphasized that home visits can prevent costly emergencies and pledged to do better. Despite the audit, Decker confirmed no immediate policy changes have been implemented. Reuters + 1

What comes next for home-health oversight

The review followed a pledge from Hemsley after UnitedHealth missed profit expectations for the first time since 2008. Previous FTI findings cited a lack of standardized documentation in HouseCalls. While the latest audit offers a largely positive assessment, ongoing oversight and evolving digital health tools—such as wearable devices integrating with medical records—could influence future operational and compliance strategies. 

Lilly results shade Kailera positive Phase 3 topline in obesity and type 2 diabetes

 

Kailera Therapeutics announces positive Phase 3 topline for oral GLP-1 HRS-7535/KAI-7535 in obesity and type 2 diabetes

  • Two Hengrui Pharma Phase 3 trials showed up to 11.1% weight loss and 1.68% HbA1c reduction with HRS-7535/KAI-7535.

India gives Meta notice to remove child sexual abuse ads



India's Ministry of Electronics and Information Technology has issued a notice to Meta over advertisements of child sexual abuse on Instagram and WhatsApp.

The Indian government warned Meta on Saturday over the presence of such ads and called for an explanation within seven days.

"The Ministry of Electronics and Information Technology (MeitY) has issued a stern notice to Meta over the presence of Child Sexual Exploitative & Abuse Material (CSEAM) in paid advertisements on Instagram," the Indian government said in a statement. "The government has directed Instagram to immediately disable all advertisements and content that promote or facilitate access to CSEAM and has sought a detailed explanation from Meta within 7 days."



BBC reported Friday that Meta was running advertisements promoting child sexual abuse material in India via Instagram. Some of those advertisements linked to Telegram pages that offered child sexual abuse material for sale.


Telegram said it has removed more than 274,000 groups from its platform due to child sexual abuse material this year.

A Meta spokesperson said the company has a "zero-tolerance policy for soliciting or sharing" child sexual abuse material.

"We use advanced AI technology to proactively detect violating content and individuals, but we are in a constant battle with criminals who hide among our 3.5 billion users and try to evade our detection," the Meta spokesperson said.

https://www.yahoo.com/news/world/articles/india-gives-meta-notice-remove-145336021.html

Endevica spinout Kalohexis submits confidential IPO filing to develop obesity challenger to GLP-1s

 Clinical-stage biotech Kalohexis is preparing for a public listing to support its obesity and cancer cachexia treatments.

Though the company has not determined how many shares it plans to offer or the price, Kalohexis revealed in a June 7 release that it has confidentially submitted the relevant IPO documents to the Securities and Exchange Commission.

Kalohexis spun out of privately owned peptide therapeutic company Endevica Bio in March to focus on treatments by leveraging the body’s melanocortin system, which regulates metabolic homeostasis. Kalohexis has developed its own peptide candidates that target central melanocortin-3 and -4 receptors (MC3R/MC4R) to treat a range of metabolic disorders.

The biotech's lead assets are 710GO, an oral dual MC3R/MC4R agonist in phase 1 development for weight loss, and mifomelatide, a injectable dual MC3R/MC4R antagonist in phase 2 for the treatment of a wasting syndrome called cachexia in patients with advanced cancers. The company also has several preclinical discovery programs.

Back when the biotech spun out of Endevica, Kalohexis Chief Medical and Scientific Officer Daniel Marks, M.D., Ph.D., said the company's approach has shown advantages over GLP-1s in the obesity space. 

“710GO has the potential to be a healthier, more durable obesity treatment than current standard of care because rather than just suppressing appetite, it changes the body's metabolic set-point,” Marks said at the time.

Marks also pointed to preclinical data that he claimed showed 710GO “did not cause the side effects common with GLP-1 receptor agonists, such as loss of lean body mass, gastrointestinal distress and rapid weight regain following treatment cessation.”

Kalohexis is led by Russell Potterfield, who has served as Endevica's CEO since 2020 after helping found the company in 2015.

Kalohexis' leadership will likely take heart from the renewed investor interest in biotech IPOs this year, which has included the $625 million offering by obesity-focused Kailera Therapeutics.

https://www.fiercebiotech.com/biotech/metabolic-biotech-kalohexis-files-confidential-ipo-develop-glp-1-challenger